Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesPayablesPensionProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Astrazeneca (AZNCF) Retained Earnings (2016 - 2025)

Historic Retained Earnings for Astrazeneca (AZNCF) over the last 17 years, with Q4 2025 value amounting to $11.0 billion.

  • Astrazeneca's Retained Earnings rose 24721.52% to $11.0 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $11.0 billion, marking a year-over-year increase of 24721.52%. This contributed to the annual value of $11.0 billion for FY2025, which is 24721.52% up from last year.
  • As of Q4 2025, Astrazeneca's Retained Earnings stood at $11.0 billion, which was up 24721.52% from $8.2 billion recorded in Q3 2025.
  • Astrazeneca's 5-year Retained Earnings high stood at $11.0 billion for Q4 2025, and its period low was -$2.5 billion during Q3 2022.
  • Over the past 5 years, Astrazeneca's median Retained Earnings value was $1.8 billion (recorded in 2021), while the average stood at $2.2 billion.
  • Per our database at Business Quant, Astrazeneca's Retained Earnings crashed by 21231.82% in 2022 and then soared by 168679.25% in 2025.
  • Astrazeneca's Retained Earnings (Quarter) stood at $1.7 billion in 2021, then plummeted by 133.57% to -$574.0 million in 2022, then skyrocketed by 361.67% to $1.5 billion in 2023, then skyrocketed by 110.39% to $3.2 billion in 2024, then soared by 247.22% to $11.0 billion in 2025.
  • Its last three reported values are $11.0 billion in Q4 2025, $8.2 billion for Q3 2025, and $7.0 billion during Q2 2025.